Žádné výsledky... Zkuste upravit dotaz a/nebo upravit či vypnout filtry.
Nejvíce citovaný článek - PubMed ID 25877855
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
The Lancet. Oncology.
2015 May ;
16 (5) :
499-508.
[epub] 20150412
